1,022 material Form 8-K filings that 830 companies we cover made with the SEC in February 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Saul Centers reported fourth quarter 2024 results on February 28, 2025. Total revenue rose to $67.9 million from $66.7 million, but net income fell to $10.4 million from $17.5 million, and FFO per diluted share fell to $0.63 from $0.79. The company attributed the profit decline mainly to initial operations at Twinbrook Quarter Phase 1, which began carrying interest, taxes and other costs as expenses after its October 1, 2024 delivery, along with lower lease termination fees.
Q4 2024 total revenue was $67.9 million, up from $66.7 million in Q4 2023.
Net income available to common stockholders was $5.3 million, or $0.22 per basic and diluted share, versus $10.4 million, or $0.43, a year earlier.
Twinbrook Quarter Phase 1 reduced quarterly net income by $6.8 million compared with the prior-year quarter.
Lower lease termination fees of $2.4 million reduced results; commercial portfolio was 95.2% leased at December 31, 2024, up from 94.1%.
Globe Life's board expanded from eleven to thirteen directors on February 26, 2025, and appointed Matthew J. Adams and Philip M. Jacobs to the newly created seats. Both were determined to be independent and named to the Audit Committee, and their terms run until the April 24, 2025 Annual Meeting of Shareholders. The filing describes routine board additions and standard director pay rather than any change in company operations or finances.
Board expanded from eleven to thirteen directors effective February 26, 2025
Matthew J. Adams and Philip M. Jacobs appointed; initial terms end at the April 24, 2025 Annual Meeting
Both named to the Audit Committee; each receives a $100,000 prorated annual cash retainer and a $180,000 prorated equity retainer, plus a $12,500 Audit Committee retainer
Acadia Healthcare entered a new credit agreement with JPMorgan Chase Bank as administrative agent, providing a $1 billion revolving facility and a $650 million term loan, both maturing February 28, 2030. The company used the proceeds to refinance obligations under its prior credit agreement, which it terminated, and the new facilities carry floating interest rates and financial covenants.
New $1 billion revolving facility and $650 million term loan, both maturing February 28, 2030
Proceeds used to refinance obligations under the Existing Credit Agreement, which was dated March 17, 2021 and scheduled to mature March 17, 2026
Borrowings bear floating rates: SOFR plus 1.375% to 2.250%, or base rate plus 0.375% to 1.250%, based on net leverage
Covenants include a Consolidated Total Net Leverage Ratio of no more than 5.0 to 1.0 and Interest Coverage of at least 3.0 to 1.0
Home BancShares said Chairman Tracy M. French will not stand for reelection as a director of the company or chairman of the board and bank board when his term ends on April 17, 2025. He will serve as an employee advisor to senior management for two years, under a retirement agreement that keeps his $408,000 salary and benefits but ends bonus eligibility and change-in-control payments.
Tracy M. French's board and chairman roles end upon completion of his current term on April 17, 2025.
He will remain an employee advisor to senior management for two years, effective February 27, 2025.
Retirement agreement keeps his $408,000 annual salary and benefits but removes bonus eligibility and change-in-control payments.
Outstanding restricted shares and stock options will continue to vest while he remains an employee.
ABM Industries entered an amended and restated credit agreement dated February 26, 2025, with Bank of America as administrative agent. The facility provides $1.6 billion of revolving commitments and $600 million of term facility commitments, both with a five-year term maturing February 26, 2030, and it refinances the company's prior credit agreement from 2017.
Revolving credit commitments of $1.6 billion and term facility commitments of $600 million, maturing February 26, 2030
Borrowings priced at a margin tied to the total net leverage ratio over Term SOFR or a base rate; commitment fee of 0.200% to 0.400%
Financial covenants include maximum total net leverage of 5.00 to 1.00, maximum secured net leverage of 4.00 to 1.00, and minimum interest coverage of 1.50 to 1.00
Initial term loan proceeds were used to refinance the Original Credit Agreement, repay part of revolving borrowings and pay transaction costs
Mohawk Industries' Chief Financial Officer William W. Harkins will resign effective March 14, 2025, to pursue another opportunity. James F. Brunk, who already serves as CFO, will also act as interim Chief Accounting Officer and Corporate Controller while the company searches for a permanent replacement. The filing does not report any financial results or guidance, and the leadership change affects the finance function.
William W. Harkins informed the company on February 25, 2025, that he will resign effective March 14, 2025, to pursue another opportunity.
James F. Brunk (age 59) will serve as Chief Accounting Officer and Corporate Controller on an interim basis, in addition to his CFO duties, effective March 14, 2025.
Brunk joined Mohawk in October 2006 and was previously Chief Accounting Officer and Corporate Controller from May 2009 until becoming CFO in April 2021.
The company is conducting a search for a permanent Chief Accounting Officer and Corporate Controller.
American Water Works approved a severance agreement for Melanie M. Kennedy, its Executive Vice President and Chief Human Resources Officer, whose separation date is March 1, 2025. The package includes 12 months of base salary of $487,953, a prorated 2025 bonus opportunity and a $300,000 supplemental cash payment, in exchange for a general release and restrictive covenants.
Separation date set for March 1, 2025; agreement approved February 28, 2025
Cash severance equal to 12 months of base salary of $487,953, plus a $300,000 supplemental payment
Prorated 2025 Annual Performance Plan award at 65% of annual base salary
Emerson agreed on February 25, 2025 to sell €500 million of 3.000% notes due 2031, €500 million of 3.500% notes due 2037, and $500 million of 5.000% notes due 2035, with closing expected March 4, 2025. The company expects net proceeds of about $1,536.7 million, to be used for general corporate purposes, commercial paper repayment, and part of the purchase price for its proposed acquisition of AspenTech; the filing notes the notes offering is not conditioned on that acquisition closing.
Euro notes: €500 million 3.000% due 2031 sold at 99.561% of principal and €500 million 3.500% due 2037 sold at 99.270%.
Dollar notes: $500 million 5.000% due 2035 sold at 99.454% of principal.
Expected net proceeds of about $1,536.7 million, before offering expenses, with closing expected March 4, 2025.
Proceeds partly fund the proposed purchase of AspenTech shares not already owned by Emerson, which the filing says may not be completed on the anticipated terms or at all.
Middlesex Water reported 2024 net income of $44.4 million and diluted EPS of $2.47, up from $31.5 million and $1.76 in 2023. Revenue rose $25.6 million to $191.9 million, driven mainly by a New Jersey base rate increase and higher weather-driven customer demand, which points to stronger earnings for shareholders.
2024 net income of $44.4 million, up $12.8 million from 2023; diluted EPS of $2.47 versus $1.76
2024 revenues of $191.9 million, up $25.6 million from $166.3 million; Middlesex System revenues rose $19.9 million on the base rate increase approved in March 2024
Fourth quarter 2024 net income of $8.8 million and diluted EPS of $0.49, versus $5.8 million and $0.32 in the fourth quarter of 2023
Board declared a first quarter 2025 dividend of $0.34 per share, payable March 3, 2025; Ocean View water utility asset purchase for about $4.6 million expected to close by April 2025
Packaging Corporation of America said CFO Robert P. Mundy will step down as Chief Financial Officer on May 1, 2025, and remain in an advisory role until his planned retirement on March 1, 2026. General Counsel Kent A. Pflederer will become Executive Vice President and CFO on the same date, with a base salary of $750,000 and eligibility for incentive and equity awards. The filing also describes related management changes, including Thomas A. Hassfurther being named President.
Robert P. Mundy steps down as CFO effective May 1, 2025; retires March 1, 2026 and keeps his current base salary until then
Kent A. Pflederer, General Counsel since 2013 and with the company since 2007, becomes EVP and CFO on May 1, 2025
Pflederer's annual base salary will be $750,000, with eligibility for annual incentive and long-term equity awards
Thomas A. Hassfurther named President; D. Ray Shirley named EVP, Corrugated Products
HealthStream disclosed that Executive Vice President Michael Sousa will resign effective March 31, 2025, and that three executives were promoted to EVP roles, including Michael Collier, Trisha Coady and Kevin O'Hara. Each promoted executive received performance-based RSUs with a grant date fair value of approximately $400,000, approved by the Compensation Committee on February 27, 2025. The changes were previously announced in the February 24, 2025 earnings release.
Michael Sousa, EVP Enterprise Applications, intends to resign effective March 31, 2025
Michael Collier promoted to EVP, Corporate Strategy, Development & Operations; Trisha Coady to EVP, Workforce Development Solutions; Kevin O'Hara to EVP, Enterprise Workforce Platform
Each promotion includes performance-based RSUs with grant date fair value of approximately $400,000, vesting in increments over 2026 to 2030, plus base salary increases
On February 25, 2025, Waste Management's Compensation Committee granted annual incentive awards to its named executive officers, including performance share units (PSUs), stock options and annual cash incentives under its 2023 Stock Incentive Plan. The filing is a routine annual grant that sets out the award terms, and it does not change the company's executive roster.
CEO James C. Fish, Jr. received 43,636 PSUs and 50,580 stock options, with options priced at $231.195 (fair market value on the grant date).
PSUs are split 50% on cash flow generation and 50% on total shareholder return relative to the S&P 500, measured through December 31, 2027, with payouts from 0% to 200% of target.
Stock options vest 34% after one year, 33% after two years and 33% after three years, and have a 10-year term.
Annual cash incentive payouts range from zero to 200% of target, based on operating EBITDA, income from operations excluding depreciation and amortization margin and internal revenue growth.
Rollins said Chief Accounting Officer and principal accounting officer Traci Hornfeck intends to resign effective March 11, 2025, to pursue another opportunity. The company said the resignation is not due to any disagreement over financial statements, internal controls, operations, policies or practices. Chief Financial Officer Kenneth D. Krause will also serve as principal accounting officer after her departure.
Traci Hornfeck notified the company on February 26, 2025 of her intention to resign, effective March 11, 2025
Hornfeck's resignation is stated not to involve any disagreement with the company
Kenneth D. Krause, Executive Vice President and CFO, will assume the principal accounting officer role
The filing states no new compensatory arrangement was made with Krause in connection with the role
Gen Digital issued $950 million of 6.250% Senior Notes due 2033 on February 28, 2025, in a private offering. The company said it used the proceeds, along with cash on hand, to repurchase all of its outstanding 5.00% Senior Notes due 2025 and pay accrued interest on them. The filing describes a refinancing that replaces near-term debt with notes maturing in 2033, though it does not report a change in total debt.
Notes: $950 million principal, 6.250% annual interest, paid semi-annually, maturing April 1, 2033
Interest payments begin October 1, 2025; the company may redeem some notes before April 1, 2028 at a make-whole price
Proceeds plus cash on hand used to repurchase all outstanding 5.00% Senior Notes due 2025
Notes sold only to qualified institutional buyers under Rule 144A and to non-U.S. investors under Regulation S
Virtu Financial Operating LLC amended the employment agreements of Co-President and Co-Chief Operating Officer Joseph Molluso and Executive Vice President, Markets Stephen Cavoli on February 26, 2025. The amendments extend each executive's initial expiration date to February 28, 2028, with other terms unchanged, which keeps two senior leaders in place for longer.
Amendments signed February 26, 2025 with Joseph Molluso and Stephen Cavoli
Initial expiration date of each employment agreement extended to February 28, 2028
All other terms of the employment agreements remain in full force
Full amendment texts to be filed as exhibits to the next Form 10-Q
The Cheesecake Factory issued $575 million of 2.00% convertible senior notes due March 15, 2030, including $75 million from the full exercise of the initial purchasers' option. The company's press release says it plans to use part of the net proceeds to repurchase $276 million of its 0.375% convertible notes due 2026 and about 2.4 million common shares, which may affect the trading price of its stock and the initial conversion price.
Notes issued February 28, 2025: $575 million principal, including $75 million from the full exercise of the initial purchasers' option; interest is payable semi-annually beginning September 15, 2025.
Initial conversion price is about $70.73 per share, a premium of about 30.0% over the $54.41 closing price on February 25, 2025; up to 10,567,868 shares may be issued on conversion at the maximum conversion rate.
Press release estimates net proceeds of about $558.5 million with the option fully exercised; about $290.0 million is earmarked to repurchase $276.0 million of 2026 notes and about $130.0 million to repurchase about 2.4 million shares.
Director John Douglas will retire from Tetra Tech's board effective February 27, 2025, and the board will shrink from seven members to six. At the February 27 annual meeting, all six nominees were elected, shareholders approved the advisory executive compensation resolution, and PricewaterhouseCoopers was ratified as auditor for fiscal 2025.
Douglas notified the company on February 24, 2025 of his retirement; he did not disclose any disagreement with the company.
Board size reduced from seven to six directors; Douglas was not presented for election at the 2025 annual meeting.
Say-on-pay advisory vote: 205,943,994 for, 17,826,706 against, 1,121,683 abstain.
PricewaterhouseCoopers ratification: 218,553,853 for, 21,056,994 against, 194,081 abstain.
TKO Group Holdings closed its acquisition of IMG, On Location and Professional Bull Riders from Endeavor on February 28, 2025. TKO issued about 26.1 million TKO Common Units valued at $3.25 billion, plus a $50 million purchase price adjustment settled in equity, and the companies mutually terminated their Services Agreement at closing. The equity was sold in private placements, so the new issuance adds to the share count for existing shareholders.
Closing consideration: about 26.1 million TKO Common Units valued at $3.25 billion, with an equivalent number of TKO PubCo Class B shares.
Services Agreement with Endeavor, dated September 12, 2023, was mutually terminated on the Closing Date.
Transaction Agreement Amendment dated February 27, 2025 moved the Inside Date to February 28, 2025.
Dollar Tree appointed Michael C. Creedon, Jr., William W. Douglas III and Timothy A. Johnson to its Board of Directors effective immediately, and amended its bylaws to raise the board size from nine to twelve. Creedon, the chief executive since December 18, 2024, is joining the board without committee roles or added pay, while Douglas and Johnson will receive standard non-employee director compensation and may join committees later.
Michael C. Creedon, Jr., CEO since December 18, 2024, joined the board; the company does not expect him to receive additional board pay.
William W. Douglas III and Timothy A. Johnson were appointed as directors; the board plans to name them to committees, with details to come in a later 8-K amendment.
Board size increased from nine to twelve directors under amended By-Laws effective February 27, 2025.
Johnson's retirement from Victoria's Secret & Co is planned for June 2025, according to the press release.
Alpha Metallurgical Resources reported a fourth-quarter 2024 net loss of $2.1 million, or $0.16 per diluted share, compared with net income of $3.8 million in the third quarter, as weak met coal demand pressured results. The company lowered its 2025 metallurgical coal shipment guidance and raised its cost of coal sales guidance, which points to lower volumes and higher per-ton costs for shareholders.
Q4 2024 net loss of $2.1 million, or $0.16 per diluted share, versus net income of $3.8 million ($0.29 per share) in Q3 2024 and $176.0 million ($12.88 per share) in Q4 2023
Adjusted EBITDA of $53.2 million, up from $49.0 million in Q3 2024 but down from $266.3 million in Q4 2023
2025 metallurgical coal shipment guidance cut to 14.5 million to 15.5 million tons from 15.0 million to 16.0 million tons
2025 cost of coal sales guidance raised to $103.00 to $110.00 per ton from $103.00 to $108.00 per ton
Brady Corporation elected Anne De Greef-Safft to its Board of Directors effective February 25, 2025, and appointed her to the Audit Committee. She will receive $135,000 in fair value of unrestricted Class A Nonvoting Common Stock under the standard non-employee director compensation program. The appointment adds a director with prior global manufacturing and public company board experience, and it does not change reported financial results.
Board election effective February 25, 2025; grant date for her stock award is also February 25, 2025
Appointed to the Audit Committee of the Board
Stock award valued at $135,000 in fair value of unrestricted Class A Nonvoting Common Stock
Previously Group President of Standex International's Food Service Equipment Group (2015 to 2017); consulted for private equity firms from 2018 to 2024
Smurfit Westrock plc director Dmitri Stockton notified the company on February 26, 2025 that he will leave the Board when the 2025 Annual General Meeting of Shareholders concludes, currently scheduled for May 2, 2025. The company said his decision was not related to any disagreement or to its operations, policies, or practices, so the change is administrative in nature for shareholders.
Dmitri Stockton notified the company on February 26, 2025 of his decision to step down from the Board.
Departure takes effect at the conclusion of the 2025 Annual General Meeting, currently scheduled for May 2, 2025.
The company states the resignation was not related to any disagreement or to company operations, policies, or practices.
Amneal reported fourth-quarter and full-year 2024 results on February 28, 2025. Net revenue rose 18% in the quarter and 17% for the year, while the GAAP net loss narrowed in the quarter but widened for the full year, and adjusted diluted EPS declined. The company also gave 2025 guidance for net revenue of $3.0 billion to $3.1 billion and adjusted EBITDA of $650 million to $675 million.
Q4 2024 net revenue was $731 million, up 18% from $617 million; GAAP net loss attributable to Amneal was $31 million, versus $99 million in Q4 2023.
Q4 2024 adjusted diluted EPS was $0.12, compared with $0.14 in Q4 2023.
Full-year 2024 net revenue was $2.79 billion, up 17%; GAAP net loss was $117 million, versus $84 million in 2023; adjusted diluted EPS was $0.58, down 9%.
2025 guidance: net revenue of $3.0 billion to $3.1 billion, adjusted EBITDA of $650 million to $675 million, and adjusted diluted EPS of $0.65 to $0.70.
AES reported full-year 2024 net income of $698 million, up from a net loss of $182 million in 2023, and Adjusted EPS of $2.14, above its $1.87 to $1.97 guidance range. Adjusted EBITDA fell $189 million to $2,639 million and total revenue declined to $12,278 million from $12,668 million, while the company initiated 2025 guidance for Adjusted EBITDA of $2,650 million to $2,850 million and Adjusted EPS of $2.10 to $2.26.
Full-year 2024 diluted EPS from continuing operations was $2.37, compared with $0.34 in 2023
Adjusted EBITDA was $2,639 million, within the $2,600 million to $2,900 million guidance range but down from $2,828 million in 2023
2025 guidance: Adjusted EBITDA of $2,650 million to $2,850 million and Adjusted EPS of $2.10 to $2.26
Quarterly dividend of $0.17595 expected to be maintained
International Paper appointed Lance Loeffler, formerly of Halliburton, as senior vice president and chief financial officer, effective April 1, 2025, succeeding Timothy Nicholls, who becomes executive vice president and president of DS Smith, a newly created role leading the company's Europe, Middle East and Africa business. For shareholders, the change brings a new CFO and a dedicated leader for the EMEA region, which the filing says will oversee integration of DS Smith.
Lance Loeffler, 48, becomes CFO effective April 1, 2025, with an annual base salary of $850,000 and a target bonus of 100% of base salary
Loeffler receives a one-time inducement RSU grant valued at $1,700,000 and a 2025 PSU grant valued at $3,500,000
Timothy Nicholls, 63, becomes executive vice president and president of DS Smith, effective April 1, 2025, reporting to CEO Andrew Silvernail
MasTec reported fourth quarter and full-year 2024 results on February 27, 2025, with revenue and GAAP net income both higher than in 2023. The company also issued initial 2025 guidance, including $13.45 billion in revenue and GAAP net income of $327 million to $366 million, and expects a GAAP net loss of $1 million in the first quarter of 2025.
Q4 2024 revenue was $3.4 billion, up from $3.3 billion; GAAP net income was $84.7 million, versus $1.2 million in Q4 2023.
Full-year 2024 GAAP net income was $199.4 million, or $2.06 per diluted share, compared with a net loss of $47.3 million in 2023.
2025 guidance: revenue of $13.45 billion, GAAP diluted EPS of $3.75 to $4.24, and adjusted EBITDA of $1.10 billion to $1.15 billion.
Estimated 18-month backlog reached a record $14.3 billion at December 31, 2024; net debt leverage ratio was 1.8x.
NW Natural Holdings reported that 2024 net income fell 16% to $78.9 million, or $2.03 per share, from $93.9 million, or $2.59 per share, in 2023, and annual operating revenue fell 4% to $1.15 billion. Excluding a non-cash regulatory disallowance and SiEnergy transaction costs, adjusted EPS was $2.33. The company also initiated 2025 GAAP EPS guidance of $2.66 to $2.86, which shareholders will weigh against the lower 2024 results.
2024 net income $78.9 million ($2.03 per share) vs. $93.9 million ($2.59 per share) in 2023; adjusted EPS $2.33
Fourth-quarter operating revenue rose 4% to $370.9 million, while fourth-quarter diluted EPS was $1.12 vs. $1.21
2025 GAAP EPS guidance $2.66 to $2.86; adjusted EPS guidance $2.75 to $2.95; long-term EPS growth target of 4% to 6% reaffirmed
Quarterly dividend of $0.49 per share paid Feb. 14, 2025; indicated annual rate $1.96 per share
Ellington Financial reported net income attributable to common stockholders of $22.4 million, or $0.25 per share, for the quarter ended December 31, 2024, up from $16.2 million, or $0.19 per share, in the third quarter. Adjusted distributable earnings were $40.6 million, or $0.45 per share, which covered the $0.39 per share in dividends for the quarter. Book value per common share was $13.52 as of December 31, 2024.
Net income attributable to common stockholders of $22.4 million, or $0.25 per share, versus $16.2 million, or $0.19 per share, in the third quarter of 2024
Adjusted distributable earnings of $40.6 million, or $0.45 per share, versus $0.39 per share in dividends for the quarter
Book value per common share of $13.52 as of December 31, 2024
Monthly dividend of $0.13 per common share declared on February 10, 2025
Illinois Tool Works entered into an amendment to its Euro-denominated credit agreement with ING Bank, N.V., London Branch, as agent, on February 24, 2025. The amendment extends the termination date to February 28, 2027, with an option to extend to September 15, 2027, and lowers the interest rate spread on loans from 0.75% to 0.70%. The company's facility is fully drawn, so the change affects the cost and term of existing borrowing rather than adding available capacity.
Amendment dated February 24, 2025, to the Euro credit agreement originally dated May 5, 2023
Termination date extended to February 28, 2027; company may extend to September 15, 2027 under stated conditions
Interest rate spread on loans decreased from 0.75% to 0.70%
€750 million outstanding; facility fully drawn with no amounts available for additional borrowing
On February 21, 2025, Albany International's Compensation Committee approved 2025 Performance Stock Unit and Restricted Stock Unit awards to certain executives, including its named executive officers. The performance units pay 0% to 200% of target based on goals for 2025 through 2027, and the restricted units vest in thirds over three years, so the awards tie executive pay to future results and continued employment.
Performance stock unit payout ranges from 0% to 200% of target, based on adjusted EBITDA, ROIC and relative total shareholder return for January 1, 2025 to December 31, 2027
Restricted stock units vest one-third on each of the first three anniversaries of the grant date, if the holder is still employed
Named executive target amounts include 16,349 shares for Gunnar Kleveland and 5,632 shares for Robert D. Starr, with the same figures for each award type
Performance results are to be determined in early 2028, with any bonus paid in full in March 2028
LeMaitre Vascular reported preliminary fourth-quarter 2024 results, with net sales of $55.7 million, up 14% from a year earlier, and diluted EPS of $0.49 versus $0.38. The company also gave 2025 guidance of $235.4 million to $242.8 million in sales and $2.15 to $2.32 in EPS, and raised its quarterly dividend 25% to $0.20 per share. Sales and earnings growth, plus the dividend increase and a share repurchase authorization of up to $75.0 million, are the main items for shareholders.
Q4 2024 net income was $11.2 million, versus $8.5 million in Q4 2023; operating income was $12.9 million, up 26%.
Gross margin was 69.3%, up from 68.1% in Q4 2023.
2025 full-year sales guidance is $235.4 million to $242.8 million, compared with 2024 sales of $219.9 million.
The quarterly dividend rises to $0.20 per share, payable March 27, 2025; the board authorized up to $75.0 million in buybacks through February 17, 2026.
Tidewater reported fourth-quarter 2024 revenue of $345.1 million, up from $302.7 million a year earlier, while quarterly net income of $36.9 million ($0.70 per diluted share) was roughly flat against $37.7 million ($0.70) in the prior-year quarter. The company also initiated 2025 revenue guidance of $1.32 billion to $1.38 billion and approved a new share repurchase program of up to $90.3 million, which management said is the maximum permitted under its existing debt agreements.
Q4 2024 revenue of $345.1 million, compared with $302.7 million for Q4 2023
Q4 2024 net income of $36.9 million ($0.70 per diluted share), compared with $37.7 million ($0.70) for Q4 2023
Full-year 2024 net income of $180.7 million ($3.40 per diluted share), up 85.9% from 2023
2025 guidance: revenue of $1.32 billion to $1.38 billion and gross margin of 48% to 50%; new buyback authorization of $90.3 million
Astrana Health reported fourth-quarter and full-year 2024 results. Revenue grew sharply, but net income attributable to Astrana fell from $60.7 million to $43.1 million for the year, and the fourth quarter swung to a $7.0 million net loss. The company also gave 2025 guidance of $2.5 billion to $2.7 billion in total revenue and $170 million to $190 million in Adjusted EBITDA.
Full-year 2024 total revenue was $2,034.5 million, up 47% from $1,386.7 million; diluted EPS was $0.90, versus $1.29 in 2023.
Fourth-quarter 2024 net loss attributable to Astrana was $7.0 million, compared with income of $12.4 million a year earlier, on revenue of $665.2 million, up 88%.
2025 guidance: total revenue of $2,500 million to $2,700 million and Adjusted EBITDA of $170 million to $190 million, excluding acquisitions not yet closed.
On February 26, 2025, the company amended its credit agreement with Truist Bank, providing for $1.3 billion in total facilities including a $745.0 million delayed draw term loan.
Amphastar Pharmaceuticals reported fourth-quarter and full-year 2024 results on February 27, 2025. Net revenues rose 5% in the quarter and 14% for the year, and GAAP diluted EPS increased from the prior-year periods, though fourth-quarter gross margin fell to 46.5% from 54.0%.
Q4 net revenues were $186.5 million, up from $178.1 million; GAAP diluted EPS was $0.74 versus $0.68 and adjusted non-GAAP diluted EPS was $0.92 versus $0.88.
Full-year net revenues were $732.0 million, up from $644.4 million; GAAP diluted EPS was $3.06 versus $2.60.
Q4 gross margin was 46.5% versus 54.0%, mainly due to lower other revenues after the Lilly Transition Service Agreement with Lilly expired in Q4 2024; BAQSIMI product revenues were $41.8 million in the quarter.
Targa Resources Corp. completed a $2.0 billion underwritten offering of senior notes due 2035 and 2055, each $1.0 billion. The company expects to use part of the proceeds to repurchase the outstanding preferred equity in Targa Badlands LLC, which holds its North Dakota assets, for about $1.8 billion in cash. For shareholders, this is a large debt-funded transaction that adds long-term borrowing while buying out a joint venture partner's stake.
$1.0 billion of 5.550% Senior Notes due 2035 and $1.0 billion of 6.125% Senior Notes due 2055 were issued on February 27, 2025.
Proceeds are expected to fund a roughly $1.8 billion cash repurchase of joint venture partner's preferred equity in Targa Badlands LLC, expected to close in the first quarter of 2025.
If the Badlands transaction does not close, proceeds will go to general corporate purposes, including repaying commercial paper borrowings.
HCI Group reported fourth-quarter 2024 net income after noncontrolling interests of $2.6 million, down from $38.1 million a year earlier, as losses from Hurricane Milton and higher ceded reinsurance premiums cut profit. For the full year, pre-tax income rose to $173.4 million and diluted EPS rose to $8.89 from $7.62, and the company said it plans to keep rates flat for the foreseeable future.
Q4 2024 GAAP diluted EPS was $0.23, versus $3.40 in Q4 2023; non-GAAP adjusted diluted EPS was $0.31, versus $3.22.
Q4 2024 losses and loss adjustment expenses were $110.7 million, including a net loss of $78.0 million from Hurricane Milton.
Full-year 2024 total revenue was $750.1 million, up from $550.7 million in 2023, and consolidated gross premiums earned rose 41.5% to $1,083.2 million.
The company will hold its earnings call on February 27, 2025 at 4:45 p.m. Eastern time.
Range Resources appointed Christian S. Kendall as a director effective February 27, 2025, to serve through the May 2025 annual meeting. Kendall has more than 30 years of oil and gas experience, including as president and CEO of Denbury before its acquisition by Exxon Mobil in November 2023. The filing describes this as a board addition and does not report any financial results or changes to company operations.
Board appointment effective February 27, 2025; Kendall serves through the annual meeting in May 2025
Director pay: $80,000 annual cash retainer and a $200,000 annual restricted stock grant or cash equivalent, the same as other non-employee directors
Kendall will serve on the ESG and Safety and Governance and Nominating committees
Board has determined Kendall is an independent director
Kinder Morgan director Deborah Macdonald notified the company on February 24, 2025, that she will retire from the Board and will not stand for re-election at the 2025 annual meeting of stockholders in May. The filing states her decision is not due to any disagreement with the company. The change is a board succession item rather than a change in operations or financial results.
Deborah Macdonald notified Kinder Morgan on February 24, 2025, of her retirement from the Board
Her current term expires at the 2025 annual meeting of stockholders in May
The filing states her decision is not due to any disagreement with KMI
Arcosa reported fourth quarter 2024 revenue up 14% to $666.2 million, helped by the $1.2 billion Stavola acquisition completed October 1, 2024, but posted a net loss of $7.7 million versus net income of $27.1 million a year earlier. Acquisition-related expenses of $15.6 million and higher interest expense weighed on results, while Adjusted EBITDA rose 52% to $128.3 million. The company guided to 2025 revenues of $2.8 billion to $3.0 billion and Adjusted EBITDA of $545 million to $595 million, with GAAP profit trends and guidance pointing in different directions for shareholders.
Q4 2024 revenue was $666.2 million, up 14% from $582.2 million; net loss was $7.7 million, or $0.16 per diluted share, versus net income of $27.1 million, or $0.56 per share, in Q4 2023.
Q4 Adjusted EBITDA rose 52% to $128.3 million; Adjusted Diluted EPS fell 32% to $0.46 from $0.68.
Full year 2025 guidance: consolidated revenues of $2.8 billion to $3.0 billion and Adjusted EBITDA of $545 million to $595 million.
Q4 free cash flow was $199.2 million; year-end net debt to Adjusted EBITDA was 2.9x, down from 3.4x at the end of the third quarter.
Erie Indemnity reported fourth-quarter 2024 net income of $152.0 million, or $2.91 per diluted share, up from $110.9 million, or $2.12, a year earlier. Full-year 2024 net income rose to $600.3 million, or $11.48 per diluted share, from $446.1 million, or $8.53, in 2023. The board also declared a quarterly Class A dividend of $1.365 per share, payable April 22, 2025.
Q4 2024 net income $152.0 million, or $2.91 per diluted share, versus $110.9 million, or $2.12, in Q4 2023
Full-year 2024 net income $600.3 million, or $11.48 per diluted share, versus $446.1 million, or $8.53, in 2023
Quarterly Class A dividend of $1.365 per share (Dividend No. 379), record and ex-dividend date April 7, 2025, payable April 22, 2025
Pre-recorded webcast on the results scheduled for 10:00 a.m. ET on February 28, 2025
Assured Guaranty reported fourth quarter 2024 net income attributable to the company of $18 million, or $0.35 per diluted share, down from $376 million, or $6.40 per share, a year earlier. The prior-year quarter included a $208 million benefit from tax law changes, and full-year 2024 net income fell to $376 million, or $6.87 per share, from $739 million, or $12.30 per share. For shareholders, the decline in reported earnings is large, though the company also repurchased $502 million of shares in 2024.
Q4 2024 adjusted operating income was $66 million, or $1.27 per share, versus $338 million, or $5.75 per share, in Q4 2023.
Full-year 2024 adjusted operating income was $389 million, or $7.10 per share, versus $648 million, or $10.78 per share, in 2023.
Q4 2024 total revenues were $156 million, versus $327 million in Q4 2023; full-year revenues were $872 million, versus $1,373 million.
As of February 27, 2025, the company was authorized to buy back about $276 million of its common shares, and it expects a gain of about $103 million in Q1 2025 from the LBIE litigation.
Monster Beverage reported fourth-quarter and full-year 2024 results, with net sales up 4.7% in the quarter to $1.81 billion. Reported net income fell 26.2% to $270.7 million because of a $130.7 million Alcohol Brands impairment charge, while adjusted net income fell 6.6% to $375.7 million. Shareholders are weighing solid sales growth against lower reported earnings and a large non-cash charge.
Q4 2024 net sales rose 4.7% to $1.81 billion; on a foreign-currency-adjusted basis, sales rose 7.8%.
Reported Q4 diluted EPS was $0.28, down from $0.35; adjusted diluted EPS was $0.38, unchanged from the prior year.
Full-year 2024 net sales rose 4.9% to $7.49 billion, and reported net income fell 7.5% to $1.51 billion.
No shares were repurchased in Q4 2024; about $500.0 million remained available under the repurchase program as of February 26, 2025.
Tutor Perini reported fourth-quarter and full-year 2024 results, with 2024 revenue up 12% to $4.3 billion and a net loss attributable to the company of $163.7 million, or $3.13 per diluted share, versus a $171.2 million loss in 2023. The company also reported record operating cash flow of $503.5 million and a record backlog of $18.7 billion, and guided to 2025 EPS of $1.50 to $1.90.
2024 revenue was $4.3 billion, up 12% from 2023, and the net loss attributable to the company narrowed from $171.2 million to $163.7 million.
Net cash provided by operating activities was $503.5 million in 2024, up 63%, and total debt was reduced by $477 million, or 52%, since the end of 2023.
Backlog reached $18.7 billion as of December 31, 2024, up 84% from $10.2 billion a year earlier.
For 2025, the company expects double-digit revenue growth and EPS of $1.50 to $1.90.
HP reported fiscal first-quarter revenue of $13.5 billion, up 2.4% from a year earlier, while GAAP diluted EPS fell to $0.59 from $0.62. HP also approved an expansion of its restructuring plan, adding about $0.3 billion in annualized savings and about $150 million in charges, with 1,000 to 2,000 additional gross workforce reductions, and it held its fiscal 2025 outlook.
Q1 fiscal 2025 net revenue $13.5 billion, up 2.4%; GAAP diluted EPS $0.59 versus $0.62, within the $0.57 to $0.63 outlook
Non-GAAP diluted EPS $0.74 versus $0.81 a year earlier, within the $0.70 to $0.76 outlook
Restructuring amendment adds about $0.3 billion in fiscal 2025 savings, bringing the total to about $1.9 billion, with about $150 million in additional charges
Incremental gross workforce reductions of about 1,000 to 2,000 employees, varying by country; fiscal 2025 non-GAAP EPS outlook of $3.45 to $3.75 held
Solventum agreed on February 25, 2025 to sell its purification and filtration business to Thermo Fisher Scientific for approximately $4.10 billion in cash, plus assumption of certain liabilities, subject to customary closing adjustments. The deal is subject to closing conditions, including antitrust clearance, and Solventum expects to close by the end of 2025, so shareholders face a pending divestiture rather than a completed sale.
Cash consideration of approximately $4.10 billion payable at closing, subject to adjustments for cash, debt, transaction expenses and working capital
Agreement dated February 25, 2025; Solventum expects to close by the end of the 2025 calendar year
Either party may terminate if the deal is not completed by November 25, 2025, with two three-month extensions available if only regulatory conditions remain unmet
Solventum agreed to a three-year non-compete for the business and a two-year non-solicit and no-hire for certain employees after closing
American Healthcare REIT reported fourth-quarter and full-year 2024 results on February 27, 2025, and issued full-year 2025 guidance. The fourth-quarter GAAP net loss per diluted share narrowed to $(0.21) from $(0.42) a year earlier, and normalized FFO per diluted share rose to $0.40 from $0.38, while full-year normalized FFO was $1.41 versus $1.40 in 2023. For 2025, the company expects normalized FFO of $1.56 to $1.60 per diluted share and total portfolio same-store NOI growth of 7.0% to 10.0%.
Q4 2024 GAAP net loss attributable to controlling interest was $(31.8) million, or $(0.21) per diluted share, versus $(27.4) million, or $(0.42), in Q4 2023.
Full-year 2024 normalized FFO was $1.41 per diluted share; total portfolio same-store NOI grew 17.7%.
2025 guidance: normalized FFO of $1.56 to $1.60 per diluted share and net income of $0.26 to $0.30 per diluted share, versus a 2024 net loss of $(0.29).
Company raised about $1.36 billion of gross equity in 2024, including $120.2 million through its at-the-market program in Q4.
Masco Corporation's board elected Heath M. Eisman, 50, as Vice President, Controller and Chief Accounting Officer, effective February 27, 2025. He previously served as the company's Director, Financial Reporting since 2014 and will receive a $310,000 annual base salary with incentive programs targeting 40% of salary. The change is a senior finance leadership appointment that shareholders may want to note, though the filing describes no change in company results or strategy.
Heath M. Eisman, 50, elected by the board on February 26, 2025, effective February 27, 2025
Annual base salary of $310,000, with target incentive opportunity of 40% of base salary under annual and long-term programs
Payouts capped at 200% of target; annual restricted stock unit award equal in value to 40% of base salary
Prior role: Director, Financial Reporting at Masco since 2014; earlier at Caterpillar Inc. and PricewaterhouseCoopers
MetLife appointed Toby Srihiran Brown, its Executive Vice President and Global Head of Reinsurance, as interim Chief Accounting Officer effective March 15, 2025, while it searches for a permanent replacement for Tamara Schock, who previously gave notice of her resignation. The board also expanded itself to fourteen directors and added Christian Mumenthaler, effective May 1, 2025.
Toby Srihiran Brown, age 51, named interim Chief Accounting Officer effective March 15, 2025
Tamara L. Schock, who gave notice of resignation on January 7, 2025, remains principal accounting officer until Brown's appointment takes effect
Board increased from thirteen to fourteen directors; Christian Mumenthaler elected, joining the Finance and Risk and Investment Committees
Non-management directors receive a $325,000 annual retainer, $175,000 in stock and $150,000 in cash
Rocket Lab reported fourth-quarter 2024 revenue of $132.4 million, up from $60.0 million a year earlier, and full-year 2024 revenue of $436.2 million, up 78% from $244.6 million. The net loss widened slightly, to $52.3 million in the quarter and $190.2 million for the year, and the company guided first-quarter 2025 revenue to $117 million to $123 million.
Q4 2024 revenue was $132.4 million versus $60.0 million in Q4 2023; Q4 net loss was $52.3 million versus $50.5 million.
Full-year 2024 revenue was $436.2 million versus $244.6 million in 2023; full-year net loss was $190.2 million versus $182.6 million.
Q1 2025 guidance calls for revenue of $117 million to $123 million, with GAAP gross margins of 25% to 27%.
Electron launched 16 times in 2024, and the company reported more than $450 million in newly secured contracts.
TransMedics reported fourth-quarter and full-year 2024 results on February 27, 2025, with revenue of $121.6 million for the quarter, up 50%, and $441.5 million for the year, up 83%. The company posted full-year net income of $35.5 million, or $1.01 per diluted share, compared with a net loss of $25.0 million in 2023, and expects 2025 revenue of $530 million to $552 million.
Q4 2024 revenue of $121.6 million, up 50% from $81.2 million; Q4 net income of $6.9 million, or $0.19 per diluted share
Full-year 2024 gross margin of 59.4%, down from 63.8% in 2023; operating expenses of $224.6 million
2025 revenue outlook of $530 million to $552 million, representing 20% to 25% growth
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.